has been cited by the following article(s):
|
[1]
|
Immunomolecular evaluation of dihydroartemisinin effects on apoptosis in chronic lymphocytic leukemia cell lines
Leukemia Research,
2021
DOI:10.1016/j.leukres.2021.106702
|
|
|
|
|
[2]
|
High Bax/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia
Leukemia Research,
2021
DOI:10.1016/j.leukres.2021.106604
|
|
|
|
|
[3]
|
High Bax/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia
Leukemia Research,
2021
DOI:10.1016/j.leukres.2021.106604
|
|
|
|
|
[4]
|
Immunomolecular evaluation of dihydroartemisinin effects on apoptosis in chronic lymphocytic leukemia cell lines
Leukemia Research,
2021
DOI:10.1016/j.leukres.2021.106702
|
|
|
|
|
[5]
|
Immunomolecular evaluation of dihydroartemisinin effects on apoptosis in chronic lymphocytic leukemia cell lines
Leukemia Research,
2021
DOI:10.1016/j.leukres.2021.106702
|
|
|
|
|
[6]
|
BAX/BCL2 ratio in chronic lymphocytic leukemia and its association with ZAP-70 expression and other clinicopathological parameters
Iraqi Journal of Hematology,
2020
DOI:10.4103/ijh.ijh_2_20
|
|
|
|